Mark Smith Biography and Net Worth

Director of Phreesia

Mark is a Professor of Clinical Medicine at the University of California at San Francisco and Visiting Professor at the School of Public Health at the University of California at Berkeley. He co-chairs the Guiding Committee of the Health Care Payment Learning and Action Network. A nationally recognized leader in healthcare improvement and health policy, Mark was the founding president and former CEO of the California HealthCare Foundation, a philanthropic organization focused on improving the health of Californians, which he led from 1996 to 2013. He was elected to the Institute of Medicine in 2001.

What is Mark Douglas Smith's net worth?: The estimated net worth of Mark Douglas Smith is at least $777,635.96 as of July 18th, 2024. Dr. Smith owns 30,653 shares of Phreesia stock worth more than $777,636 as of March 15th. This net worth evaluation does not reflect any other investments that Dr. Smith may own. Learn More about Mark Douglas Smith's net worth.
How do I contact Mark Douglas Smith?: The corporate mailing address for Dr. Smith and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at investors@phreesia.com. Learn More on Mark Douglas Smith's contact information.
Has Mark Douglas Smith been buying or selling shares of Phreesia?: Mark Douglas Smith has not been actively trading shares of Phreesia during the last quarter. Most recently, Mark Douglas Smith sold 7,000 shares of the business's stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $25.00, for a transaction totalling $175,000.00. Following the completion of the sale, the director now directly owns 30,653 shares of the company's stock, valued at $766,325. Learn More on Mark Douglas Smith's trading history.
Who are Phreesia's active insiders?: Phreesia's insider roster includes Edward Cahill (Director), Balaji Gandhi (CFO), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Mark Smith (Director), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.
Are insiders buying or selling shares of Phreesia?: In the last twelve months, insiders at the sold shares 83 times. They sold a total of 378,140 shares worth more than $9,592,827.15. The most recent insider tranaction occured on February, 18th when COO Evan Roberts sold 3,519 shares worth more than $105,781.14. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.
Information on this page was last updated on 2/18/2025.

Mark Douglas Smith Insider Trading History at Phreesia

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/18/2024	Sell	7,000	$25.00	$175,000.00	30,653
4/3/2023	Sell	7,000	$30.77	$215,390.00	16,112
1/4/2021	Sell	6,000	$52.57	$315,420.00

Mark Douglas Smith Buying and Selling Activity at Phreesia

Phreesia Company Overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Today's Range

Now: $25.37

$24.54

$25.87

50 Day Range

MA: $27.31

$21.90

$29.99

2 Week Range

Now: $25.37

$17.07

$30.53

Volume

804,595 shs

Average Volume

432,702 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.03